Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut Bergonié
This project is an exploratory study, based on the hypothesis of involvement of chemokines in hormonal escape of prostate cancers.
The two main objectives are:
* To describe the variations in expression of chemokines in serum and urine level in patients with prostate cancer
* And to study the disease stage and intra-prostatic concentrations of chemokines based on serum and urine concentrations of chemokines before treatment initiation.
These estimates can be used in future trials set up for the management of prostate cancer
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with a localized or metastatic prostate adenocarcinoma for which a new treatment will be implemented (hormone therapy for single biological relapse or relapses and metastatic hormone-sensitive) or chemotherapy (for biological relapses and / or metastatic hormone-resistant)
Patients with a detectable PSA (Prostate-Specific Antigen)
Patients who signed an informed consent
Patients over 18 years
Patients belonging to the social security scheme
You may not be if
Active Hepatitis B or C virus
HIV positive
Patients who have received prior chemotherapy
Patients with a second neoplasia treated in the last 5 years
